Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 32Colonic Neoplasms 20Rectal Neoplasms 11Carcinoma, Hepatocellular 7Neoplasm Metastasis 5Stomach Neoplasms 2Neoplastic Cells, Circulating 2Neoplasms 2Liver Neoplasms 2Recurrence 1Peritoneal Neoplasms 1Pathologic Complete Response 1Pancreatic Neoplasms 1Oligometastatic Gastric Adenocarcinoma 1Neuroendocrine Tumors 1Neoplasms, Second Primary 1Neoplasm, Residual 1Neoplasm Recurrence, Local 1Margins of Excision 1Locally Advanced Rectal Cancer 1Gastro-enteropancreatic neuroendocrine tumor 1Gallbladder Neoplasms 1Cholangiocarcinoma 1Biliary Tract Neoplasms 1

Interventions

tislelizumab 1motexafin gadolinium 1Tamoxifen 1Talaporfin 1Radiotherapy 1Oxaliplatin 1Mitomycin 1Lomustine 1Irinotecan 1Gemcitabine 1Folfox protocol 1Fluorouracil 1Ethiodized Oil 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Neoplasm Recurrence, Local × Folfox protocol × Clear all
NCT00440310 2015-08-25

Phase 3 Trial of Litxâ„¢ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases

Light Sciences Oncology

Phase 3 Completed
483 enrolled 7 charts
Gastrointestinal

Liver Neoplasms, Neoplasm Metastasis, Neoplasm Recurrence, Local, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡